Incidence and etiology of hepatic dysfunction in heart transplant recipients receiving a cyclosporine-based triple immunosuppressive therapy.
Jazzar
A
A
Oklahoma Transplantation Institute, Baptist Medical Center, Oklahoma City 73112.
Fagiuoli
S
S
Caraceni
P
P
Deal
S
S
Wright
H I
HI
Sisson
S
S
Gavaler
J
J
Van Thiel
D H
DH
Zuhdi
N
N
Cooper
D K
DK
D001379:Azathioprine / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury; D016572:Cyclosporine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D008107:Liver Diseases / Q000453:epidemiology*; D008111:Liver Function Tests; D013997:Time Factors
D016572:Cyclosporine; D001379:Azathioprine